CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
115178-34-2 | (5R,8S,10R)-6-methyl-8-((2-phenyl-1h-imidazol-1-yl)methyl)ergoline | |
| |
115178-33-1 | (5R,8S,10R)-8-((2-isopropyl-1h-imidazolyl)methyl)-6-methylergoline | |
| |
115178-32-0 | 8-((2-ethyl-1h-imidazol-1-yl)methyl)-6-methylergoline (8-alpha)- | |
| |
115178-31-9 | 8-((2-methyl-1h-imidazol-1-yl)methyl)-6-methylergoline (8-alpha)- | |
| |
115178-30-8 | 2-triazol-1-ylmethyl)- 6-methyl-8-(1h- (8-alpha)-ergolin | |
| |
115178-28-4 | (8-alpha)-ergolin | |
| |
115175-22-9 | 3-amino-n-(3-chlorophenyl)-benzamide | |
C13H11ClN2O | 246.69 |
115174-20-4 | (2-(hexahydro-1(2h)-azocinylmethyl)benzyl)-guanidin sulfate | |
| |
115174-18-0 | (3-(hexahydro-1(2h)-azocinylmethyl)benzyl)-guanidin sulfate | |
| |
115174-16-8 | (4-(hexahydro-1(2h)-azocinylmethyl)benzyl)-guanidin sulfate | |
| |
115169-13-6 | borate(1-), (1,3-butanediolato(2-)-o,o')diphenyl-(t-4)-, hydrogen, compd. with | |
| |
115169-11-4 | 1- dodecanamine (1:1) | |
| |
115169-10-3 | borate(1-), diphenyl(1,3-propanediolato(2-)-o,o')-(t-4)-, hydrogen, compd. with | |
| |
115169-08-9 | diphenyl-borinic aci 4-hydroxy-1-methylpentyl ester | |
| |
115169-07-8 | diphenyl-borinic aci 6-hydroxyhexyl ester | |
| |
115160-07-1 | naltrexone phenyl oxime | |
| |
115150-59-9 | arginyl-tryptophyl-n-methylphenylalanyl-tryptophyl-leucyl-methioninamide | |
C49H66N12O6S | 951.19 |
115150-38-4 | benzoic acid, 2-((3-(2-((4-((methoxycarbonyl)amino)phenyl)sulfonyl)hydrazino)-1 | |
| |
115150-37-3 | benzoic acid, 2-((3-(2-((4-methylphenyl)sulfonyl)hydrazino)-1,3-dioxopropyl)ami | |
| |
115150-36-2 | 2-((1,3-dioxo-3-(2-(phenylsulfonyl)hydrazino)propyl)amino)-benzoic aci | |
| |
115147-60-9 | 2h-azepin-2-one, hexahydro-, polymer with 2,6-dimethylphenol, block | |
| |
115144-40-6 | 3,4-二氟苯甲醚 3,4-difluoroanisole | 密度:1.23
|
C7H6F2O | 144.12 |
115144-39-3 | rac-1,2-dimyristoyl-3-palmitoylglycerol | |
C47H90O6 | 751.22 |
115144-38-2 | 1,2-dimyristoyl-3-lauroyl-rac-glycerol | |
C43H82O6 | 695.12 |
115141-47-4 | 3,2-mn)thiazolo(5,4-b)acridine-9-ethanamine, n,n,1-trimethyl-1h-pyrido( | |
| |
115141-43-0 | h-d-thr(tbu)-ome . hcl | |
CHNO3.HCl | 111.48 |
115136-18-0 | chromogranin a-derived peptide, we-14 | |
C72H116N18O24S | 1649.87 |
115136-07-7 | leu(13)-psi-ch2nh-leu(14)-bombesi | |
| |
115133-44-3 | bmy 26225 | |
| |
115132-19-9 | n-boc-erythro-dl-beta-methylphenylalanine | 熔点:109-112℃
|
C15H21NO4 | 279.33 |
115124-72-6 | glyicne, n-((phenylmethoxy)carbonyl)-, (5-fluoro-3,4-dihydro-2,4-dioxo-1(2h)-py | |
| |
115120-53-1 | phosphoric acid, mixed bu and c12_16-alkyl esters, ammonium salts | |
| |
115120-51-9 | phosphoric acid, c8_16-alkyl esters, compds. with 2-ethyl-1-hexanamine | |
| |
115120-50-8 | phosphoric acid, c14_18 and c16_18-unsatd. alkyl esters | |
| |
115120-49-5 | phosphoric acid, c8_16-alkyl esters | |
| |
115120-48-4 | phosphoric acid, c10_16-alkyl esters | |
| |
115116-41-1 | 2:2:3) | |
| |
115115-49-6 | 16b-bromoandrosterone | |
C19H29BrO2 | 369.34 |
115112-73-7 | berodual | |
| |
115109-65-4 | 5-(4-(9-fluorenylmethyloxycarbonyl)aminomethyl-3,5-dimethoxyphenoxy)valeric aci | 密度:1.2g/cm3 沸点:733.0℃ at 760 mmHg (Predicted)
|
C29H31NO7 | 505.56 |
115104-28-4 | verlukast | |
C26H26ClN2NaO3S2 ·xH2O | 537.07 |
115103-54-3 | 4-bis(3-methyl-2-thienyl)-3-butenyl)- 1-( (R)-3-piperidinecarboxylic aci | |
C20H25NO2S2 | 375.55 |
115103-15-6 | tribendimidine | |
C28H32N6 | 452.59 |
115102-25-5 | dimethyl-carbamic aci anhydride with tetraethylphosphorodiamidic acid | |
| |
115100-56-6 | benzenediazonium, 4-[(2-methoxyphenyl)azo]-2-methyl-5-[(2-nitro-4-sulfophenyl)a | |
| |
115100-55-5 | iron, complexes with diazotized 3-aminobenzenesulfonic acid coupled with diazot | |
| |
115100-54-4 | ferrate(5-), bis[4-[[2,4-dihydroxy-5-[(2-methoxyphenyl)azo]-3-[[4-(phenylamino) | |
| |
1151-97-9 | 2-(2,4-二硝基苯甲基)吡啶 2-[(2,4-dinitrophenyl)methyl]-pyridin | 熔点:90-93℃
|
C12H9N3O4 | 259.22 |
1151-94-6 | 4-methoxy-4′-nitrobenzophenone | 密度:1.264±0.06 g/cm3(Predicted) 熔点:125-127 °C
|
C14H11NO4 | 257.24 |
1151-74-2 | methylisopropylamiloride | |
| |